Developer docs
API playgroundTry for free, no card

Search company profiles

Avacen Medical

Full company profile

uuid000cyjz

Namestring
Avacen Medical
Legal namestring
AVACEN, Inc.
Websiteurl
avacen.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Avacen Medical (legal entity AVACEN, Inc.) is a Carlsbad, California-based medical device company founded in 2009 by Thomas Muehlbauer and Danielle J. Forsgren that develops and markets FDA 510(k)-cleared Class II thermotherapy devices under its patented AVACEN Treatment Method (ATM). The core technology combines controlled heat with negative pressure applied through the palm of the hand to activate high-volume arteriovenous anastomoses (AVAs), enabling systemic heat infusion and enhanced microcirculation from a single point of contact. The portfolio spans consumer/home devices (AVACEN HOME XL, GXL Gold Edition), a professional-grade device with commercial licensing (AVACEN PRO+), and a diagnostic cardiovascular and stress screening system (AVACEN CSS) using accelerated plethysmography and heart rate variability analysis, with CE Mark and Health Canada approvals supporting international distribution.

The company operates a hybrid go-to-market: direct-to-consumer e-commerce (shop.avacen.com) supported by an affiliate network; professional sales to clinicians and wellness practitioners with CPT-reimbursable testing on the CSS device (codes 95921, 95922, 93922 at approximately $67 per test midpoint); and enterprise channel partnerships — most notably distribution into the VA Health System's 1,380 facilities via B&B Health Services and placement in 200+ OsteoStrong wellness centers serving 25,000+ members. Reported revenue exceeds $20 million with 79% three-year growth, qualifying the company for five consecutive years on the Inc. 5000 list (2020–2024). The company has raised only modest external capital (a $2M round in 2014 and $285,538.88 via StartEngine in 2023), making it largely self-funded.

Customer reach includes 8,000+ devices deployed globally with over 40 million safe treatments administered and no adverse events reported in clinical use. The company monetizes primarily through one-time hardware sales (consumer devices in the low-thousands range; CSS at $9,995 purchase or ~$7.33/day lease), recurring CPT-billed professional services, leasing via MedOne Capital, and affiliate/referral commissions ($300 per qualified referral). Strategic recent moves include the 2024 OsteoStrong international partnership, 2024–2025 VA Health System distribution via B&B Health Services, and an October 2025 co-development partnership with BrainIQ Health bundling AVACEN hardware with nutrition products in a broader wellness ecosystem.

Short descriptiontext

Avacen Medical is a Carlsbad, California medical device company that develops and markets FDA-cleared Class II palm-based thermotherapy devices and a cardiovascular stress screening system, sold direct-to-consumer, to healthcare practitioners, and through enterprise partnerships with the VA Health System and OsteoStrong wellness centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
palm-based thermotherapy, microcirculation therapy, pain management devices, cardiovascular screening systems, noninvasive medical devices
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pain Management Medical Devices
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Device Sales (Consumer)
TypeHardware Sales
Description

Direct-to-consumer sales of AVACEN home devices including AVACEN Home XL and AVACEN GXL Gold Edition through the company's e-commerce storefront and affiliate network. One-time hardware purchase with optional extended warranties.

avacen.com
2Professional Device Sales
TypeHardware Sales
Description

Sales of AVACEN PRO+ and professional-grade devices to healthcare practitioners, wellness centers, and spas. Includes commercial license allowing practitioners to charge for treatments.

avacen.com
3CSS Device Sales/Leasing
TypeHardware Sales
Description

Sales and leasing of the Cardiovascular & Stress Screening (CSS) system to healthcare practitioners. Leasing available through MedOne Capital for as little as $7.33 per day. The 5-minute test is reimbursable up to 3 times per year per patient under CPT codes.

avacen.com
4CPT Reimbursement
TypeProfessional Services
Description

Healthcare practitioners can seek reimbursement for CSS cardiovascular stress screening tests using CPT codes 95921, 95922, and 93922. The midpoint for these codes is approximately $67 per test.

avacen.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Pricing details4 tiers
1AVACEN CSS Device - Purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$9,995 with 3-year warranty. Includes HP laptop, Canon printer, PPG sensor, and travel carrying bag. Professional practitioners can seek CPT reimbursement of approximately $67 per test.

avacen.com
2AVACEN CSS Device - Leasing
ModelSubscriptionBilling cadenceMonthly
Notes

As low as $7.33 per day through MedOne Capital for qualified health practitioners. Or $11 per day when leased in conjunction with AVACEN PRO+ professional device.

avacen.com
3Trade-In/Trade-Up Program
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$2,000 off current price if trade-in device is less than 36 months old. $1,500 off for older devices. $500 'customer appreciation' discount for devices not in good condition. Program valid through March 31, 2026.

avacen.com
4Customer Referral Program
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

$300 award for existing users who refer a new AVACEN device purchaser. Affiliates also receive commission for every qualified customer purchase. Program valid through March 31, 2026.

avacen.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1AVACEN Wellness
Description

Wellness product line available at avacenwellness.com

avacen.com
+5 more records
Core offering1 text field

Avacen Medical manufactures and sells FDA 510(k)-cleared Class II palm-based thermal therapy medical devices that use heat combined with negative pressure to enhance systemic microcirculation through arteriovenous anastomoses. Its product line spans consumer/home-use devices (AVACEN HOME XL, AVACEN GXL Gold Edition), a professional-grade practitioner system (AVACEN PRO+) with a commercial license for charging treatments, and the AVACEN CSS diagnostic system for cardiovascular and stress screening using APG and HRV analysis.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Over 40% reduction in pain indicators after 28 days of treatment for fibromyalgia patients
+5 more records
Product overview1 text field

AVACEN Medical offers a portfolio of FDA Cleared Class II over-the-counter thermotherapy medical devices based on its proprietary AVACEN Treatment Method (ATM), which uses heat and negative pressure applied through the palm to enhance microcirculation throughout the body. The product line includes consumer/home-use devices (AVACEN HOME XL, AVACEN GXL Gold Edition), professional/practitioner devices (AVACEN PRO+ with commercial licensing), and diagnostic equipment (AVACEN CSS Cardiovascular & Stress Screening System). The AVACEN CSS is a separate diagnostic tool using HRV and APG technology for cardiovascular screening. The company also offers accessories and replacement parts through its online store, with the original AVACEN 100 now considered a legacy product.

Product and service6 records
1AVACEN HOME XL
CategoryPain Management Medical Device (Consumer/Home Use)
Description

FDA 510(k)-cleared, over-the-counter, noninvasive medical device for home use providing palm-based heat therapy for temporary relief of minor muscle pain, joint pain, stiffness, joint pain associated with arthritis, muscle spasms, minor strains and sprains, muscular relaxation, and temporary increase of local circulation. Features color touch screen, video and sound, robust extended-life design, larger hand accommodation, extended treatment sessions, and pop-on/pop-off cuff.

2AVACEN PRO+
CategoryPain Management Medical Device (Professional/Practitioner)
Description

FDA 510(k)-cleared professional-grade heat therapy system with commercial license enabling practitioners to charge for treatments. Includes color touch screen, Wi-Fi, Bluetooth, and RFID support for custom AVACEN Apps, pop-on/pop-off cuff design, 5x reliability improvement over prior PRO, support for over 100 languages, and educational videos plus meditation music. Indicated for temporary relief of minor muscle and joint pain, arthritis pain, muscle spasms, minor strains and sprains, muscular relaxation, and temporary increase of local circulation.

3AVACEN GXL (Gold Edition)
CategoryPain Management Medical Device (Consumer/Luxury Variant)
Description

Luxury Gold Edition heat therapy device featuring a classic gold finish, designed for spas, doctor's offices, and home décor. Includes a 5-year warranty and 30-day money-back guarantee. Provides the same FDA-cleared AVACEN Treatment Method as other consumer devices.

4AVACEN CSS (Cardiovascular & Stress Screening) System
CategoryCardiovascular & Stress Diagnostic Medical Device (Practitioner)
Description

FDA 510(k)-cleared Class II diagnostic device for healthcare practitioners that measures Heart Rate Variability through Accelerated Plethysmography (APG) to analyze cardiovascular and autonomic nervous system function. Supports CPT codes 95921, 95922, and 93922 for reimbursement. Provides 1-, 3-, and 5-minute HRV analyses with a 2-page printed summary and digital patient history summary. Analyzes arterial elasticity, peripheral elasticity, physical/mental stress, chronic fatigue, and electrocardiac stability. Available for purchase at $9,995 or leased through MedOne Capital at $7.33/day.

5AVACEN 100
CategoryPain Management Medical Device (Legacy)
Description

Original FDA-cleared Class II OTC medical device providing noninvasive palm-based heat therapy using the AVACEN Treatment Method to warm blood systemically. First AVACEN device to receive CE Mark and Health Canada approval for fibromyalgia pain management. Proven safe with over 2 million uses reported without adverse effects. Now considered a legacy product, predecessor to the AVACEN HOME XL line.

6AVACEN Accessories
CategoryDevice Accessories and Replacement Parts
Description

Accessories and replacement parts for AVACEN devices, including the proprietary Pop-On/Pop-Off Cuff (XL/PRO+ exclusive), VCI Refresh Kit, and other consumables supporting continued safe operation of AVACEN devices.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-02
Description

Partnership combining BrainIQ's neuroscience-driven nutrition products (GLP-1 supplements, brain health capsules, sleep gummies, NAD products) with AVACEN's microcirculation technology. The collaboration creates a next-generation wellness ecosystem for brain health, performance, pain relief, sleep, and longevity.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-12-24
Description

AVACEN Medical was featured in the 'Biohack Yourself' documentary on Amazon Prime Video, showcasing its revolutionary device and microcirculation technology. The documentary provides brand exposure to wellness-focused audiences worldwide.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-11-11
Description

Partnership through which AVACEN Medical provides its FDA-cleared AVACEN palm-based thermo-therapy medical devices to the VA Health System. B&B Health Services facilitates distribution to VA healthcare providers serving millions of veterans annually.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-10-07
Description

Joint marketing events including 'The Power of Microcirculation' sessions with Danielle Forsgren and Strong Talks presentations. Special discounts offered to OsteoStrong members for AVACEN device testing and purchases.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-08-21
Description

AVACEN Medical executed an agreement with OsteoStrong, the leading provider of advanced wellness solutions. AVACEN provides its proprietary, patented products for use in over 200 OsteoStrong locations and for purchase by its over 25,000 members. This international partnership supports OsteoStrong's fast-paced expansion while bringing AVACEN technology to a broader wellness audience.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Leasing partner providing financing options for health practitioners to lease the AVACEN CSS device. Qualified practitioners can lease for as little as $7.33 per day or $11 per day when bundled with the AVACEN PRO+ professional device.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership with Dr. Howard Cohn's BioStacking Summit and Cohn Health Institute for wellness education and promotion. AVACEN served as Super Sponsor with $500 discount offers for VIP members.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

iHeart (Internal Logic) manufactures HRV and autonomic nervous system measurement devices used by clinicians for cardiovascular and stress assessment. It directly competes with the AVACEN CSS diagnostic system in the practitioner HRV screening market.

TypeDirect peer
Description

Hyperice makes consumer and professional thermal therapy, percussion, and recovery devices used in sports, wellness, and pain management. It competes with AVACEN in the premium consumer thermal therapy / recovery category and shares a similar DTC + professional channel strategy.

TypeDirect peer
Description

BioElectronics manufactures FDA-cleared medical devices using PEMF and other energy modalities for pain management, recovery, and post-surgical healing. It is a direct competitor to AVACEN in the OTC and prescription pain management device category.

TypeDirect peer
Description

BEMER manufactures FDA-cleared PEMF (Pulsed Electromagnetic Field) devices specifically positioned to enhance microcirculation and support cardiovascular health. This is AVACEN's closest direct competitor, as both companies target systemic microcirculation improvement with at-home, non-invasive therapeutic devices.

TypeDirect peer
Description

Therabody manufactures percussive therapy and wellness devices (Theragun, RecoveryAir, etc.) for consumer and professional pain relief, recovery, and performance. It overlaps with AVACEN's consumer pain management and wellness positioning and competes for similar DTC and practitioner channels.

TypeBroad incumbent
Description

Hologic is a large diversified medical device and diagnostics company with products spanning women's health, cardiovascular diagnostics, and connected health. While much broader, Hologic represents the kind of scaled incumbent that could enter or consolidate the cardiovascular and stress diagnostic space where AVACEN CSS competes.

TypeBroad incumbent
Description

DJO / Chattanooga manufactures a broad portfolio of medical therapeutic modalities including thermal, ultrasound, and electrotherapy devices used in physical therapy and pain management. It is a broad incumbent in the therapeutic device market overlapping with AVACEN's professional practitioner segment.

TypeDirect peer
Description

HeartMath develops HRV-based stress and biofeedback products and technology for clinicians and consumers. It is a direct peer to AVACEN's CSS Cardiovascular & Stress Screening system, which also uses HRV analysis to assess autonomic function and stress.

TypeDirect peer
Description

Thermotex makes infrared heat therapy products marketed for chronic pain, arthritis, and musculoskeletal conditions. It is a direct peer in the consumer thermal therapy device market, particularly competing in the arthritis and chronic pain home-use segment.

TypeBroad incumbent
Description

BTL Industries manufactures medical devices for pain management, aesthetics, and rehabilitation, including shockwave, electromagnetic, and thermal-based therapy systems. It competes with AVACEN in the clinical pain management and rehabilitation practitioner market with a broader modality portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Avacen Medical

Pain Management Medical Devicesavacen.com

Avacen Medical is a Carlsbad, California medical device company that develops and markets FDA-cleared Class II palm-based thermotherapy devices and a cardiovascular stress screening system, sold direct-to-consumer, to healthcare practitioners, and through enterprise partnerships with the VA Health System and OsteoStrong wellness centers.

What Avacen Medical does

Avacen Medical (legal entity AVACEN, Inc.) is a Carlsbad, California-based medical device company founded in 2009 by Thomas Muehlbauer and Danielle J. Forsgren that develops and markets FDA 510(k)-cleared Class II thermotherapy devices under its patented AVACEN Treatment Method (ATM). The core technology combines controlled heat with negative pressure applied through the palm of the hand to activate high-volume arteriovenous anastomoses (AVAs), enabling systemic heat infusion and enhanced microcirculation from a single point of contact. The portfolio spans consumer/home devices (AVACEN HOME XL, GXL Gold Edition), a professional-grade device with commercial licensing (AVACEN PRO+), and a diagnostic cardiovascular and stress screening system (AVACEN CSS) using accelerated plethysmography and heart rate variability analysis, with CE Mark and Health Canada approvals supporting international distribution.

The company operates a hybrid go-to-market: direct-to-consumer e-commerce (shop.avacen.com) supported by an affiliate network; professional sales to clinicians and wellness practitioners with CPT-reimbursable testing on the CSS device (codes 95921, 95922, 93922 at approximately $67 per test midpoint); and enterprise channel partnerships — most notably distribution into the VA Health System's 1,380 facilities via B&B Health Services and placement in 200+ OsteoStrong wellness centers serving 25,000+ members. Reported revenue exceeds $20 million with 79% three-year growth, qualifying the company for five consecutive years on the Inc. 5000 list (2020–2024). The company has raised only modest external capital (a $2M round in 2014 and $285,538.88 via StartEngine in 2023), making it largely self-funded.

Customer reach includes 8,000+ devices deployed globally with over 40 million safe treatments administered and no adverse events reported in clinical use. The company monetizes primarily through one-time hardware sales (consumer devices in the low-thousands range; CSS at $9,995 purchase or ~$7.33/day lease), recurring CPT-billed professional services, leasing via MedOne Capital, and affiliate/referral commissions ($300 per qualified referral). Strategic recent moves include the 2024 OsteoStrong international partnership, 2024–2025 VA Health System distribution via B&B Health Services, and an October 2025 co-development partnership with BrainIQ Health bundling AVACEN hardware with nutrition products in a broader wellness ecosystem.

Avacen Medical firmographics

Firmographics
Name
Avacen Medical
Legal name
AVACEN, Inc.
Website
https://avacen.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Avacen Medical is a Carlsbad, California medical device company that develops and markets FDA-cleared Class II palm-based thermotherapy devices and a cardiovascular stress screening system, sold direct-to-consumer, to healthcare practitioners, and through enterprise partnerships with the VA Health System and OsteoStrong wellness centers.
Ownership category
akta.pro rank

Where Avacen Medical is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Avacen Medical business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

  1. Device Sales (Consumer): Direct-to-consumer sales of AVACEN home devices including AVACEN Home XL and AVACEN GXL Gold Edition through the company's e-commerce storefront and affiliate network. One-time hardware purchase with optional extended warranties.
  2. Professional Device Sales: Sales of AVACEN PRO+ and professional-grade devices to healthcare practitioners, wellness centers, and spas. Includes commercial license allowing practitioners to charge for treatments.
  3. CSS Device Sales/Leasing: Sales and leasing of the Cardiovascular & Stress Screening (CSS) system to healthcare practitioners. Leasing available through MedOne Capital for as little as $7.33 per day. The 5-minute test is reimbursable up to 3 times per year per patient under CPT codes.
  4. CPT Reimbursement: Healthcare practitioners can seek reimbursement for CSS cardiovascular stress screening tests using CPT codes 95921, 95922, and 93922. The midpoint for these codes is approximately $67 per test.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goAVACEN CSS Device - Purchase
SubscriptionMonthlyAVACEN CSS Device - Leasing
One time/ perpetual licensePay-as-you-goTrade-In/Trade-Up Program
Transaction based/ take ratePay-as-you-goCustomer Referral Program

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Avacen Medical product offering

Product offering

Core offering

Avacen Medical manufactures and sells FDA 510(k)-cleared Class II palm-based thermal therapy medical devices that use heat combined with negative pressure to enhance systemic microcirculation through arteriovenous anastomoses. Its product line spans consumer/home-use devices (AVACEN HOME XL, AVACEN GXL Gold Edition), a professional-grade practitioner system (AVACEN PRO+) with a commercial license for charging treatments, and the AVACEN CSS diagnostic system for cardiovascular and stress screening using APG and HRV analysis.

Product overview

AVACEN Medical offers a portfolio of FDA Cleared Class II over-the-counter thermotherapy medical devices based on its proprietary AVACEN Treatment Method (ATM), which uses heat and negative pressure applied through the palm to enhance microcirculation throughout the body. The product line includes consumer/home-use devices (AVACEN HOME XL, AVACEN GXL Gold Edition), professional/practitioner devices (AVACEN PRO+ with commercial licensing), and diagnostic equipment (AVACEN CSS Cardiovascular & Stress Screening System). The AVACEN CSS is a separate diagnostic tool using HRV and APG technology for cardiovascular screening. The company also offers accessories and replacement parts through its online store, with the original AVACEN 100 now considered a legacy product.

Differentiator

Problem solved

Functional benefit

Brands

  • AVACEN Wellness: Wellness product line available at avacenwellness.com
  • AVACEN Shop
  • AVACEN CSS
  • AVACEN HOME XL
  • AVACEN GXL
  • AVACEN PRO+

Products and services

  • AVACEN HOME XL FDA 510(k)-cleared, over-the-counter, noninvasive medical device for home use providing palm-based heat therapy for temporary relief of minor muscle pain, joint pain, stiffness, joint pain associated with arthritis, muscle spasms, minor strains and sprains, muscular relaxation, and temporary increase of local circulation. Features color touch screen, video and sound, robust extended-life design, larger hand accommodation, extended treatment sessions, and pop-on/pop-off cuff.
  • AVACEN PRO+ FDA 510(k)-cleared professional-grade heat therapy system with commercial license enabling practitioners to charge for treatments. Includes color touch screen, Wi-Fi, Bluetooth, and RFID support for custom AVACEN Apps, pop-on/pop-off cuff design, 5x reliability improvement over prior PRO, support for over 100 languages, and educational videos plus meditation music. Indicated for temporary relief of minor muscle and joint pain, arthritis pain, muscle spasms, minor strains and sprains, muscular relaxation, and temporary increase of local circulation.
  • AVACEN GXL (Gold Edition) Luxury Gold Edition heat therapy device featuring a classic gold finish, designed for spas, doctor's offices, and home décor. Includes a 5-year warranty and 30-day money-back guarantee. Provides the same FDA-cleared AVACEN Treatment Method as other consumer devices.
  • AVACEN CSS (Cardiovascular & Stress Screening) System FDA 510(k)-cleared Class II diagnostic device for healthcare practitioners that measures Heart Rate Variability through Accelerated Plethysmography (APG) to analyze cardiovascular and autonomic nervous system function. Supports CPT codes 95921, 95922, and 93922 for reimbursement. Provides 1-, 3-, and 5-minute HRV analyses with a 2-page printed summary and digital patient history summary. Analyzes arterial elasticity, peripheral elasticity, physical/mental stress, chronic fatigue, and electrocardiac stability. Available for purchase at $9,995 or leased through MedOne Capital at $7.33/day.
  • AVACEN 100 Original FDA-cleared Class II OTC medical device providing noninvasive palm-based heat therapy using the AVACEN Treatment Method to warm blood systemically. First AVACEN device to receive CE Mark and Health Canada approval for fibromyalgia pain management. Proven safe with over 2 million uses reported without adverse effects. Now considered a legacy product, predecessor to the AVACEN HOME XL line.
  • AVACEN Accessories Accessories and replacement parts for AVACEN devices, including the proprietary Pop-On/Pop-Off Cuff (XL/PRO+ exclusive), VCI Refresh Kit, and other consumables supporting continued safe operation of AVACEN devices.

Quantifiable outcome

  • Over 40% reduction in pain indicators after 28 days of treatment for fibromyalgia patients
  • +5 more outcomes

Companies that use Avacen Medical

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Avacen Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Avacen Medical partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • BrainIQ HealthcoreStrategic or Co-development Partner · 2 October 2025Partnership combining BrainIQ's neuroscience-driven nutrition products (GLP-1 supplements, brain health capsules, sleep gummies, NAD products) with AVACEN's microcirculation technology. The collaboration creates a next-generation wellness ecosystem for brain health, performance, pain relief, sleep, and longevity.
  • Biohack Yourself DocumentaryminorGTM or Marketing Partner · 24 December 2024AVACEN Medical was featured in the 'Biohack Yourself' documentary on Amazon Prime Video, showcasing its revolutionary device and microcirculation technology. The documentary provides brand exposure to wellness-focused audiences worldwide.
  • B&B Health ServicescoreChannel Partner/ Reseller/ Distributor · 11 November 2024Partnership through which AVACEN Medical provides its FDA-cleared AVACEN palm-based thermo-therapy medical devices to the VA Health System. B&B Health Services facilitates distribution to VA healthcare providers serving millions of veterans annually.
  • OsteoStrong (Event Partnership)minorGTM or Marketing Partner · 7 October 2024Joint marketing events including 'The Power of Microcirculation' sessions with Danielle Forsgren and Strong Talks presentations. Special discounts offered to OsteoStrong members for AVACEN device testing and purchases.
  • OsteoStrongcoreChannel Partner/ Reseller/ Distributor · 21 August 2024AVACEN Medical executed an agreement with OsteoStrong, the leading provider of advanced wellness solutions. AVACEN provides its proprietary, patented products for use in over 200 OsteoStrong locations and for purchase by its over 25,000 members. This international partnership supports OsteoStrong's fast-paced expansion while bringing AVACEN technology to a broader wellness audience.
  • MedOne CapitalminorChannel Partner/ Reseller/ DistributorLeasing partner providing financing options for health practitioners to lease the AVACEN CSS device. Qualified practitioners can lease for as little as $7.33 per day or $11 per day when bundled with the AVACEN PRO+ professional device.
  • Cohn Health Institute / BioStacking SummitminorGTM or Marketing PartnerPartnership with Dr. Howard Cohn's BioStacking Summit and Cohn Health Institute for wellness education and promotion. AVACEN served as Super Sponsor with $500 discount offers for VIP members.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Avacen Medical competitors and assessment

Company assessment

Direct peers

  • iHeart (Internal Logic): iHeart (Internal Logic) manufactures HRV and autonomic nervous system measurement devices used by clinicians for cardiovascular and stress assessment. It directly competes with the AVACEN CSS diagnostic system in the practitioner HRV screening market.
  • Hyperice: Hyperice makes consumer and professional thermal therapy, percussion, and recovery devices used in sports, wellness, and pain management. It competes with AVACEN in the premium consumer thermal therapy / recovery category and shares a similar DTC + professional channel strategy.
  • BioElectronics Corporation: BioElectronics manufactures FDA-cleared medical devices using PEMF and other energy modalities for pain management, recovery, and post-surgical healing. It is a direct competitor to AVACEN in the OTC and prescription pain management device category.
  • BEMER Group: BEMER manufactures FDA-cleared PEMF (Pulsed Electromagnetic Field) devices specifically positioned to enhance microcirculation and support cardiovascular health. This is AVACEN's closest direct competitor, as both companies target systemic microcirculation improvement with at-home, non-invasive therapeutic devices.
  • Therabody: Therabody manufactures percussive therapy and wellness devices (Theragun, RecoveryAir, etc.) for consumer and professional pain relief, recovery, and performance. It overlaps with AVACEN's consumer pain management and wellness positioning and competes for similar DTC and practitioner channels.
  • HeartMath: HeartMath develops HRV-based stress and biofeedback products and technology for clinicians and consumers. It is a direct peer to AVACEN's CSS Cardiovascular & Stress Screening system, which also uses HRV analysis to assess autonomic function and stress.
  • Thermotex: Thermotex makes infrared heat therapy products marketed for chronic pain, arthritis, and musculoskeletal conditions. It is a direct peer in the consumer thermal therapy device market, particularly competing in the arthritis and chronic pain home-use segment.

Broad incumbents

  • Hologic: Hologic is a large diversified medical device and diagnostics company with products spanning women's health, cardiovascular diagnostics, and connected health. While much broader, Hologic represents the kind of scaled incumbent that could enter or consolidate the cardiovascular and stress diagnostic space where AVACEN CSS competes.
  • Chattanooga Group (DJO): DJO / Chattanooga manufactures a broad portfolio of medical therapeutic modalities including thermal, ultrasound, and electrotherapy devices used in physical therapy and pain management. It is a broad incumbent in the therapeutic device market overlapping with AVACEN's professional practitioner segment.
  • BTL Industries: BTL Industries manufactures medical devices for pain management, aesthetics, and rehabilitation, including shockwave, electromagnetic, and thermal-based therapy systems. It competes with AVACEN in the clinical pain management and rehabilitation practitioner market with a broader modality portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Avacen Medical social profiles

Digital presence

Avacen Medical compliance and trust

Trust signal

Compliance3 records

Avacen Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Avacen Medical leadership team

Management profile

Number of profiles

Profiles13 records

Avacen Medical funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Avacen Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avacen Medical

What does Avacen Medical do?

Avacen Medical manufactures and sells FDA 510(k)-cleared Class II palm-based thermal therapy medical devices that use heat combined with negative pressure to enhance systemic microcirculation through arteriovenous anastomoses. Its product line spans consumer/home-use devices (AVACEN HOME XL, AVACEN GXL Gold Edition), a professional-grade practitioner system (AVACEN PRO+) with a commercial license for charging treatments, and the AVACEN CSS diagnostic system for cardiovascular and stress screening using APG and HRV analysis.

Is Avacen Medical a public or private company?

Avacen Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Avacen Medical founded?

Avacen Medical was founded in 2009. It employs 11 to 50 people.

Where is Avacen Medical based?

Avacen Medical is headquartered in San Diego, United States, in the North America region.

How does Avacen Medical make money?

Four revenue lines are on record. Device Sales (Consumer) is the primary driver. The others are professional Device Sales, CSS Device Sales/Leasing and CPT Reimbursement.

Who are Avacen Medical's main competitors?

Direct peers on record are iHeart (Internal Logic), Hyperice, BioElectronics Corporation, BEMER Group, Therabody, HeartMath and Thermotex. Broad incumbents are Hologic, Chattanooga Group (DJO) and BTL Industries.

Does Avacen Medical have an API?

No public API is recorded for Avacen Medical.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireAVACEN Medical Products Now Available to the VA Health SystemAVACEN Medical announced it will continue providing its FDA-cleared AVACEN palm-based thermo-therapy medical devices to the VA Health System during 2026, following its first full year of doing so in 2025. The devices are intended to offer non-opioid pain relief and post-traumatic stress solutions across the VA's 1,380 health facilities that serve over 9 million Veterans annually. The company, founded in 2009 and headquartered in Carlsbad, California, reports having delivered over 40 million safe treatments to date.EIN PresswireNarrated Fibromyalgia Study Results Now AvailableAVACEN Medical announced the availability of a narrated review of its fibromyalgia pilot study, which was conducted by UC San Diego and the Department of Veterans Affairs. The 28-day follow-up study showed a statistically significant reduction of over 40% in the widespread pain index and a decrease in tender point count below the clinical assessment threshold for fibromyalgia. The company states its FDA-cleared AVACEN device has a safety record of over 40 million treatments with no reported adverse events.EIN PresswireAVACEN Medical, Welcomes Integrative Wellbeing InstituteAVACEN Medical announced a partnership with the Integrative Wellbeing Institute (IWI) to review and organize its product research for the scientific community. IWI will evaluate AVACEN’s technologies through studies and case reports focused on health issues such as diabetes, fibromyalgia, autism, and cerebral blood flow.EIN PresswireAVACEN Medical to Further Study Autism ResultsAVACEN Medical announced plans to further study improved prefrontal cortex oxygenation and parasympathetic tone results experienced by users of its medical device, following a double-blind, placebo-controlled study in children with Autism Spectrum Disorder. The study found positive trends including reported improvements in sleep quality, expressive language, vocabulary, and social engagement among participants using the active device. The company believes these results may correspond to the well-documented phenomenon of behavioral normalization in autistic children during moderate fever.PR NewswireAVACEN Medical Awarded Certificates of Recognition for Advancing Medical ScienceAVACEN Medical, a medical device company specializing in noninvasive pain relief, received two innovation certificates of recognition from California State Treasurer Fiona Ma at the company's Carlsbad headquarters. The awards acknowledge the company's contribution to addressing chronic pain and reducing prescription opioid use, which Treasurer Ma described as an estimated $40 billion economic drain on California's economy. AVACEN Medical has been listed on the INC. 5000 for three consecutive years and manufactures FDA-cleared drug-free pain management devices.PR NewswireAVACEN Medical® Welcomes Anthony Shimkin as New Chief Executive OfficerAnthony Shimkin has been appointed Chief Executive Officer of AVACEN Medical, bringing over 25 years of medical and technology commercialization experience to the role. The company, which manufactures noninvasive drug-free pain management devices, stated that Shimkin will be responsible for driving brand awareness, expanding go-to-market strategy, and increasing revenue growth as it continues to expand globally. Shimkin previously held senior marketing and business development positions at Qualcomm and several healthcare and life sciences companies.PR NewswireAVACEN Medical Announces Results from Type 2 Diabetes Clinical StudyAVACEN Medical announced results from a 50-person sponsored clinical study on glucose tolerance in Type 2 diabetics, conducted at San Diego State University's Clinical Nutrition and Physiological Sciences Laboratory. The double-blind randomized controlled pilot study found a 62 mg/dl reduction in postprandial blood glucose after 30 minutes of AVACEN heat and vacuum device use compared to sham and heat-only controls. The company CEO highlighted the device's potential as a convenient method for Type 2 diabetics to lower blood glucose at home, noting that a similar reduction would typically require approximately one hour of moderate exercise.PR NewswireAVACEN Medical Celebrates Its Spa & Wellness Division Launch With Celebrities Attending the 90th Academy AwardsAVACEN Medical announced the launch of its new Spa & Wellness Division, expanding the availability of its AVACEN 100 heat therapy device to spas, wellness clinics, and cruise lines globally. The company marked this expansion with a gift lounge event at the 90th Academy Awards in Beverly Hills and secured partnerships with venues such as the La Valencia Hotel for April 2018 deployment.PR NewswireAVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong KongAVACEN Medical announced the launch of its AVACEN 100 dry-heat therapy medical device in Hong Kong specifically for autism spectrum disorder behavior management, targeting a market of approximately 25,000 registered autistic children in the region. The company is offering a discounted price of $1,495 (reduced from $2,995) for families with autistic children, contingent on their participation in a 60-day money-back trial that requires daily diaries and video documentation of their child's progress. The company plans to use the feedback from these trials alongside existing U.S. clinical trial data to seek FDA approval for treating ASD behavior with the AVACEN 100 in the United States.PR NewswireMedical Device for Relief of Autistic Behavior to be Launched in IndiaAVACEN Medical announced the launch of its FDA-cleared AVACEN 100 dry-heat therapy device in India to provide relief for autistic behavior, with discounted pricing offered to families with autistic children who participate in a 60-day trial with daily progress diaries. The company plans to use the feedback and clinical data from these trials to support a future FDA application for autism treatment approval in the United States. According to cited 2017 Hindustan Times data, approximately 13 million people in India live with autism spectrum disorder.